OOIR: Observatory of International Research

Papers

(The H4-Index of Annals of Laboratory Medicine is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Rapid Targeted Sequencing Using Dried Blood Spot Samples for Patients With Suspected Actionable Genetic Diseases	83
Prediction of Mid-term Platelet Transfusion in Stable Trauma Patients Using Rotational Thromboelastometry	48
A Case of Bidirectional ABO- and RhD-Incompatible Liver Transplantation in a Mongolian Patient With Asian-Type DEL	47
Validation of High-sensitivity Flow Cytometry for Reliable Immune Cell Analysis in Real-world Laboratory Settings	47
A Novel Fibrinogen Assay Using Recombinant Batroxobin and Carboxymethyl Chitosan: Carboxymethyl Chitosan Stimulates the Enzymatic Activity of Recombinant Batroxobin	46
Reinterpreting National Whole-genome Sequencing Data: Lessons from the First Korean Pilot Study	44
A New Strategy for Evaluating the Quality of Laboratory Results for Big Data Research: Using External Quality Assessment Survey Data (2010–2020)	44
Challenges of Carbapenem-resistant Pseudomonas aeruginosa in Infection Control and Antibiotic Management	36
Reducing Microbial Contamination in Hematopoietic Stem Cell Products and Quality Improvement Strategy: Retrospective Analysis of 1996-2021 Data	34
Optimization of a Protocol for Isolating Cell-free DNA From Cerebrospinal Fluid	34
Cost-effective BRCA Testing in Advanced Ovarian Cancer	33
RNA Sequencing for Elucidating an Intronic Variant of Uncertain Significance (SDHD c.314+3A>T) in Splicing Site Consensus Sequences	33
Current Status of Serum Insulin and C-Peptide Measurement in Clinical Laboratories: Experience from 94 Laboratories in China	32
Rapid Targeted Genomic Testing: A Powerful Tool for Diagnostic Evaluation of Critically Ill Neonates and Infants With Suspected Genetic Diseases	31
Development and Performance Validation of a Comprehensive Liquid Biopsy Genotyping Panel for Pan-cancer Analysis	28
In-vitro Activities of Zoliflodacin and Solithromycin Against Neisseria gonorrhoeae Isolates from Korea	28
Performance Evaluation of the i-SmartCare 10 Analyzer and Method Comparison of Six Point-of-Care Blood Gas Analyzers	28
Optimization of the Total Testing Process Within the Big Data-to-Big Data Loop	26
Performance Evaluation of Whole-Genome Amplification Platforms for Clinical Next-Generation Sequencing with Minimal Nucleic Acid Input	26
Clinical Practice Guideline for Blood-based Circulating Tumor DNA Assays	22
Clinical Differences in Patients Infected withFusobacteriumand Antimicrobial Susceptibility ofFusobacteriumIsolates Recovered at a Tertiary-Care Hospital in Korea	21
Complement Activation and Hemolysis in Non-human Primates Following Transfusion of Genetically Modified Pig Red Blood Cells	21